< /p>
Pharmaceutical company “Servier Ukraine” actively supports the solidarity movement to help the state and Ukrainians affected by a full-scale war.
The Servier Company supports Ukrainians through various humanitarian aid channels. Thanks to the established “Ukraine Solidarity Fund”, support in the amount of 1.5 million euros was provided. In addition, the company donated Servier medicines to more than 231 hospitals throughout Ukraine and focused on the safety of Ukrainian colleagues and their families.
How companies managed to create their own fund and direct a lot of resources to help the state – find out in the material.
How the Solidarity Fund of Ukraine helps during the war
The Servier Group has created a charitable foundation to provide financial support organizations operating in Ukraine.
Employees of the company around the world helped the Solidarity Fund of Ukraine raise 1.5 million euros. They immediately supported the charity initiative and made personal contributions. The management of Servier decided to further encourage such activity: for every euro that an employee donated to the fund, the company donated another euro.
With such great support from Servier and other French companies of the Center for Crisis Relief and Support of the Ministry for Europe and Foreign Affairs, France was able to provide humanitarian support in Ukraine, as well as in Moldova, Slovakia and Poland. Hundreds of thousands of IDPs seeking refuge from the war have received emergency shelters and medical supplies. In addition, ambulances and electric generators were purchased for the needs of the refugees.
At the same time, Servier continues to provide emergency kits, collects food, clothing, school supplies, and toys.
< p>
Servier employees join the company's humanitarian mission/Photo from Servier Ukraine Facebook
Helping Ukrainians in hospitals
During the war, Servier Ukraine is actively involved in supporting Ukrainians in hospitals.
- Currently, the company has already provided charitable assistance to Servier medicines in the amount of 31.1 million hryvnias, which were received more than 231 hospitals across the country. In particular, assistance was also transferred to the regions most affected by the occupation and hostilities.
- Among the drugs provided, the cost of medicines for the treatment of cancer is UAH 4.3 million.
- In addition to drugs, Servier Ukraine provided financial assistance for the purchase of necessary equipment and medical supplies in the amount of UAH 1.6 million. The company continues to respond to requests from health care institutions.
- Servier Ukraine provided free of charge 10,000 packs of its own drug for controlling glucose in patients with type 2 diabetes. The aid was donated to the needs of the Ministry of Health of Ukraine.
- The company allocated another 1 million hryvnias to support and organize shelter, food, treatment and rehabilitation of internally displaced persons.
Support for Ukrainian colleagues
< p> The Servier group pays special attention to ensuring the safety of its employees and their families in Ukraine. The company provided opportunities to move its employees and their families to safe places both in Ukraine and abroad.
Great support is also provided by the employees of Servier, who are in solidarity with their Ukrainian colleagues. From the first days of the war, the management and subsidiaries in the states bordering Ukraine began to act: for the employees who remained in the country, they were given the opportunity to move to safer territories and organized accommodation. And Ukrainians who decided to leave were met by colleagues and helped with subsequent accommodation in reception centers or in the families of employees.
Servier is an international pharmaceutical group working in such areas as cardiovascular and metabolic, oncological, neurological and immunoinflammatory diseases. To facilitate access to healthcare for a wide range of patients, the company also offers a range of generic medicines in most therapeutic areas. Servier is an independent group of companies that annually invests more than 20% of its revenue from the sale of branded medicines in research and development. Servier has been operating in Ukraine for more than 20 years.
